tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Nurix Therapeutics price target raised to $30 from $24 at Mizuho
The FlyNurix Therapeutics price target raised to $30 from $24 at Mizuho
6d ago
ONC
NRIX
BeOne Medicines announces new data on sonrotoclax
PremiumThe Fly
BeOne Medicines announces new data on sonrotoclax
8d ago
ONC
BeOne Medicines Ltd. Grants 21,274 RSUs to Employees
PremiumCompany Announcements
BeOne Medicines Ltd. Grants 21,274 RSUs to Employees
12d ago
6160
BeOne Medicines says FDA grants Priority Review to NDA for sonrotoclax
PremiumThe Fly
BeOne Medicines says FDA grants Priority Review to NDA for sonrotoclax
20d ago
ONC
BeOne Medicines initiated with a Buy at Truist
PremiumThe Fly
BeOne Medicines initiated with a Buy at Truist
22d ago
ONC
BeOne Medicines price target raised to $408 from $395 at RBC Capital
PremiumThe FlyBeOne Medicines price target raised to $408 from $395 at RBC Capital
28d ago
ONC
BeOne Medicines: Buy Rating Driven by Robust Global Vision and Strong Financial Performance
Premium
Ratings
BeOne Medicines: Buy Rating Driven by Robust Global Vision and Strong Financial Performance
29d ago
ONC
BeOne Medicines price target raised to $420 from $398 at Jefferies
Premium
The Fly
BeOne Medicines price target raised to $420 from $398 at Jefferies
29d ago
ONC
Jazz Pharmaceuticals price target raised to $205 from $185 at Morgan Stanley
PremiumThe Fly
Jazz Pharmaceuticals price target raised to $205 from $185 at Morgan Stanley
29d ago
ONC
JAZZ
Zymeworks’ Ziihera shows efficacy in Phase 3 adenocarcinoma trial
PremiumThe Fly
Zymeworks’ Ziihera shows efficacy in Phase 3 adenocarcinoma trial
29d ago
ONC
JAZZ
BeOne Medicines reports ‘positive’ results from Phase 3 HERIZON-GEA-01 trial
PremiumThe Fly
BeOne Medicines reports ‘positive’ results from Phase 3 HERIZON-GEA-01 trial
29d ago
ONC
BeOne Medicines Grants RSUs to Employees
PremiumCompany Announcements
BeOne Medicines Grants RSUs to Employees
1M ago
6160
BeOne Medicines price target raised to $405 from $399 at Citi
PremiumThe FlyBeOne Medicines price target raised to $405 from $399 at Citi
1M ago
ONC
BeOne Medicines price target raised to $390 from $383 at Morgan Stanley
Premium
The Fly
BeOne Medicines price target raised to $390 from $383 at Morgan Stanley
1M ago
ONC
BeOne Medicines price target raised to $396 from $348 at Citizens JMP
Premium
The Fly
BeOne Medicines price target raised to $396 from $348 at Citizens JMP
1M ago
ONC
BeOne Medicines: Strong Market Position and Promising Growth Prospects Drive Buy Rating
PremiumRatings
BeOne Medicines: Strong Market Position and Promising Growth Prospects Drive Buy Rating
1M ago
ONC
BeOne Medicines Announces Q3 2025 Financial Results and Business Updates
PremiumCompany Announcements
BeOne Medicines Announces Q3 2025 Financial Results and Business Updates
1M ago
6160
BeOne Medicines Ltd. Announces Form 10-Q Filing
PremiumCompany Announcements
BeOne Medicines Ltd. Announces Form 10-Q Filing
1M ago
6160
BeOne Medicines reports Q3 non-GAAP EPS $2.65, consensus 86c
PremiumThe Fly
BeOne Medicines reports Q3 non-GAAP EPS $2.65, consensus 86c
1M ago
ONC
BeOne Medicines narrows FY25 revenue view to $5.1B-$5.3B from $5.0B-$5.3B
PremiumThe FlyBeOne Medicines narrows FY25 revenue view to $5.1B-$5.3B from $5.0B-$5.3B
1M ago
ONC
BeOne Medicines Secures Regulatory Waivers for Enhanced Flexibility
Premium
Company Announcements
BeOne Medicines Secures Regulatory Waivers for Enhanced Flexibility
2M ago
6160
BeOne Medicines Ltd. to Announce Q3 2025 Financial Results
Premium
Company Announcements
BeOne Medicines Ltd. to Announce Q3 2025 Financial Results
2M ago
6160

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >